{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:34:12Z","timestamp":1787495652843,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.diabres.2015.01.016","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T15:40:49Z","timestamp":1421854849000},"page":"309-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["C-peptide: New findings and therapeutic possibilities"],"prefix":"10.1016","volume":"107","author":[{"given":"John","family":"Wahren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2015.01.016_bib0340","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1126\/science.157.3789.697","article-title":"Insulin biosynthesis: evidence for a precursor","volume":"157","author":"Steiner","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.diabres.2015.01.016_bib0345","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s00018-005-5180-6","article-title":"Separate functional features of proinsulin C-peptide","volume":"62","author":"Henriksson","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.diabres.2015.01.016_bib0350","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.96.23.13318","article-title":"Specific binding of proinsulin C-peptide to human cell membranes","volume":"96","author":"Rigler","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diabres.2015.01.016_bib0355","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bbrc.2014.07.012","article-title":"A subdivided molecular architecture with separate features and stepwise emergence among proinsulin C-peptides","volume":"450","author":"Landreh","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2015.01.016_bib0360","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","article-title":"Relaxin family peptides and their receptors","volume":"93","author":"Bathgate","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.diabres.2015.01.016_bib0365","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1172\/JCI113339","article-title":"Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects","volume":"81","author":"Polonsky","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2015.01.016_bib0370","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI109106","article-title":"Kinetics of human connecting peptide in normal and diabetic subjects","volume":"62","author":"Faber","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2015.01.016_bib0375","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0026-0495(87)90044-8","article-title":"Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man","volume":"36","author":"Henriksen","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2015.01.016_bib0380","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00018-004-4313-7","article-title":"Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity","volume":"61","author":"Melles","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.diabres.2015.01.016_bib0385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/dc08-1241","article-title":"Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients","volume":"32","author":"Panero","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.01.016_bib0390","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.01.016_bib0395","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/MOT.0b013e32835c28c5","article-title":"Follow-up of secondary diabetic complications after pancreas transplantation","volume":"18","author":"Boggi","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.diabres.2015.01.016_bib0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00402543","article-title":"The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients","volume":"35","author":"Johansson","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0405","first-page":"976","article-title":"Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1","volume":"77","author":"Johansson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.01.016_bib0410","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF00418540","article-title":"C-peptide improves autonomic nerve function in IDDM patients","volume":"39","author":"Johansson","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00403963","article-title":"C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y","volume":"39","author":"Ohtomo","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0420","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1681\/ASN.2005080797","article-title":"C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells","volume":"17","author":"Al-Rasheed","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0425","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1530\/JOE-13-0203","article-title":"Evidence for an interaction between proinsulin C-peptide and GPR146","volume":"218","author":"Yosten","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0430","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/BF00401369","article-title":"Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients","volume":"35","author":"Johansson","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.niox.2003.08.004","article-title":"Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide","volume":"9","author":"Wallerath","year":"2003","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.diabres.2015.01.016_bib0440","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1007\/s00018-004-4258-x","article-title":"C-peptide stimulates Na+, K+-ATPase via activation of ERK1\/2 MAP kinases in human renal tubular cells","volume":"61","author":"Zhong","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.diabres.2015.01.016_bib0445","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00125-004-1404-9","article-title":"Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells","volume":"47","author":"Al-Rasheed","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/0264-6021:3550123","article-title":"Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein","volume":"355","author":"Kitamura","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.diabres.2015.01.016_bib0455","doi-asserted-by":"crossref","first-page":"49747","DOI":"10.1074\/jbc.M408268200","article-title":"Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity","volume":"279","author":"Al-Rasheed","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2015.01.016_bib0460","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1096\/fj.00-0183com","article-title":"C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction","volume":"14","author":"Scalia","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.diabres.2015.01.016_bib0465","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00125-003-1232-3","article-title":"Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats","volume":"46","author":"Kitamura","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0470","doi-asserted-by":"crossref","first-page":"e28294","DOI":"10.1371\/journal.pone.0028294","article-title":"C-Peptide increases Na, K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells","volume":"6","author":"Galuska","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2015.01.016_bib0475","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/CS19990241","article-title":"Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I","volume":"98","author":"Forst","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2015.01.016_bib0480","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1097\/01.ASN.0000077339.20759.A3","article-title":"Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants","volume":"14","author":"Fiorina","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0485","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2337\/db13-0039","article-title":"C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0490","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00125-011-2251-0","article-title":"C-peptide reduces high glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation","volume":"54","author":"Cifarelli","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0495","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2337\/db12-0293","article-title":"C-Peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0500","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/dmrr.2409","article-title":"Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes","volume":"29","author":"Luppi","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2015.01.016_bib0505","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cvr\/cvt238","article-title":"Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice","volume":"101","author":"Lim","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2015.01.016_bib0510","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1210\/me.2009-0391","article-title":"Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways","volume":"24","author":"Hills","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0515","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dmrr.612","article-title":"Influence of C-peptide on early glomerular changes in diabetic mice","volume":"22","author":"Maezawa","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2015.01.016_bib0520","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00125-006-0152-4","article-title":"C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice","volume":"49","author":"Lindenblatt","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0525","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00125-008-1032-x","article-title":"Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway","volume":"51","author":"Luppi","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00011-011-0384-8","article-title":"C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia","volume":"61","author":"Haidet","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.diabres.2015.01.016_bib0535","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00125-010-1736-6","article-title":"Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein","volume":"53","author":"Mughal","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0540","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s001250100570","article-title":"C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB\/Wor rat","volume":"44","author":"Sima","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0545","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2337\/diabetes.52.7.1812","article-title":"Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition","volume":"52","author":"Cotter","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0550","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1152\/ajpendo.00048.2004","article-title":"C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB\/Wor rats","volume":"287","author":"Stevens","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.01.016_bib0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.410180105","article-title":"Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities","volume":"18","author":"Sima","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0560","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.277.5325.563","article-title":"Prevention of vascular and neural dysfunction in diabetic rats by C-peptide","volume":"277","author":"Ido","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.diabres.2015.01.016_bib0565","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.26.5.466","article-title":"Pain in peripheral neuropathy related to rate and kind of fiber degeneration","volume":"26","author":"Dyck","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.diabres.2015.01.016_bib0570","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ana.20295","article-title":"C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes","volume":"56","author":"Kamiya","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diabres.2015.01.016_bib0575","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/diabetes.52.2.536","article-title":"Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes","volume":"52","author":"Ekberg","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/dc06-1274","article-title":"C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy","volume":"30","author":"Ekberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.01.016_bib0585","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/diacare.27.5.1153","article-title":"Natural progression of diabetic peripheral neuropathy in the Zenarestat study population","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2015.01.016_bib0590","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1464-5491.2000.00274.x","article-title":"Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus","volume":"17","author":"Johansson","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2015.01.016_bib0595","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9343(85)90284-0","article-title":"The changing natural history of nephropathy in type I diabetes","volume":"78","author":"Krolewski","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2015.01.016_bib0600","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(12)70217-2","article-title":"An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics","volume":"20","author":"Fioretto","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2015.01.016_bib0605","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1523-1755.1998.00074.x","article-title":"Effects of C-peptide on renal function at the early stage of experimental diabetes","volume":"54","author":"Sj\u00f6quist","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2015.01.016_bib0610","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1046\/j.1523-1755.2001.00964.x","article-title":"Effects of C-peptide on glomerular and renal size and renal function in diabetic rats","volume":"60","author":"Samneg\u00e5rd","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2015.01.016_bib0615","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/gfh683","article-title":"C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats","volume":"20","author":"Samneg\u00e5rd","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2015.01.016_bib0620","doi-asserted-by":"crossref","first-page":"F1265","DOI":"10.1152\/ajprenal.00228.2009","article-title":"Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption","volume":"297","author":"Nordquist","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2015.01.016_bib0625","first-page":"A323","article-title":"Stimulation of blood flow by C-peptide in patients with type 1 diabetes","volume":"44","author":"Ekberg","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0630","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-201X.1996.426147000.x","article-title":"Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat","volume":"156","author":"Lindstr\u00f6m","year":"1996","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.diabres.2015.01.016_bib0635","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI2147","article-title":"Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus","volume":"101","author":"Forst","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2015.01.016_bib0640","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1152\/ajpendo.00236.2003","article-title":"C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients","volume":"286","author":"Johansson","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2015.01.016_bib0645","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2337\/diabetes.51.10.3077","article-title":"C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes","volume":"51","author":"Hansen","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0650","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2337\/diab.27.9.895","article-title":"Reduced erythrocyte deformability in diabetes","volume":"27","author":"McMillan","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2015.01.016_bib0655","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s001250051180","article-title":"The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus","volume":"42","author":"Kunt","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2015.01.016_bib0660","doi-asserted-by":"crossref","first-page":"730594","DOI":"10.1155\/2008\/730594","article-title":"C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients","volume":"2008","author":"Hach","year":"2008","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.diabres.2015.01.016_bib0665","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2015.01.016_bib0670","first-page":"S455","article-title":"Pharmacokinetics, safety, and tolerability of a long-acting C-peptide (CBX129801) in patients with type 1 diabetes","volume":"55","author":"Foyt","year":"2012","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T01:22:54Z","timestamp":1537924974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0168822715000248"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.016","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-peptide: New findings and therapeutic possibilities","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2015.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}